Laminins Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global laminins market was valued at USD 230.5 million in 2025 and is projected to reach USD 487.2 million by 2034, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 2026-2034. Laminins are high-molecular-weight glycoproteins forming a critical component of the extracellular matrix. These heterotrimeric proteins (composed of alpha, beta, and gamma chains) serve as biological scaffolds essential for cellular adhesion, differentiation, and tissue development. Their crucial role in embryogenesis, tissue repair, and cell signaling has established laminins as indispensable tools in biomedical research and regenerative medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15312/laminins-market

Global Pertussis Vaccine Market to Grow at a CAGR of 3.8% by 2032 According to a newly published market research report by 24LifeSciences, global pertussis vaccine market was valued at USD 4,917 million in 2024 and is projected to reach USD 6,341 million by 2031, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025-2031. Pertussis vaccines, which protect against whooping cough caused by the Bordetella pertussis bacterium, are critical components of global immunization programs. These vaccines are available as whole-cell (wP) and more commonly used acellular (aP) formulations, with the latter offering a refined safety profile. Their established role in preventing severe respiratory illness, particularly in vulnerable infant populations, continues to underpin their public health importance and drive consistent market demand across both pediatric and adult vaccination schedules. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7394/pertussis-vaccine-market